Marjolein Geurts
16PUBLICATIONS
50CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Mar 27, 2026
Delta-like ligand 3 expression in isocitrate dehydrogenase-mutant and isocitrate dehydrogenase-wildtype glioma is largely retained at recurrence, supporting its potential as a therapeutic target.Rosa Luning, Sybren L N Maas, Pim J French
|Mar 09, 2026
Drawing parallels between amyloid PET in Alzheimer's disease and amino acid PET in primary and secondary brain tumors.Nelleke Tolboom, Antoine Verger, Matthias Preusser
|Mar 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?Marjolein Geurts, Luzia Berchtold, Franz Koenig
|Oct 10, 2024
Updated EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection-Update 1.Martin J van den Bent, Enrico Franceschi, Mehdi Touat
|May 09, 2024
State of the Art in Low-Grade Glioma Management: Insights From Isocitrate Dehydrogenase and Beyond.Lauren R Schaff, Maria Ioannou, Marjolein Geurts
|Jan 15, 2024
Gender balance and suitable positive actions to promote gender equality among healthcare professionals in neuro-oncology: The EANO positive action initiative.Emilie Le Rhun, Florien Boele, Giuseppe Minniti
Pageof 3
Frequent Collaborators
5 joint publications
Martin J van den Bent
5 joint publications
Matthias Preusser
3 joint publications
Pim J French
3 joint publications
Michael Weller
2 joint publications
Pierre A Robe
1 joint publications
Tom J Snijders
1 joint publications
Jan C Buckner
1 joint publications
Derek R Johnson
1 joint publications
Levi van Hijfte
1 joint publications
Aline Paixao Becker
